Vicore Pharma Holding AB

VCRENasdaq Sweden Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.860 B

$10.16 -0.39%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#78Zai LabZLAB$2.96B
#79ImmunomeIMNM$2.92B
#80Vicore Pharma Holding ABVCRE$2.86B
#81PrecigenPGEN$2.82B
#82NewAmsterdam PharmaNAMS$2.79B

What if Vicore Pharma Holding AB were worth as much as…

Open the what-if tool →

Gold $30.2T

$107,393.33

Per share 10,570× higher

Bitcoin $1.74T

$6,186.49

Per share 609× higher

Nvidia $5.52T

$19,592.42

Per share 1,928× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Vicore Pharma Holding AB are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.